Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Aug 2026 for Orchestra BioMed Holdings, Inc., €14k.
Filing timeline
BuySaleAndrew Lawrence Taylor
Insider track record
Disclosed buys
6
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+19.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Andrew Lawrence Taylor: trading record in brief
Andrew Lawrence Taylor, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Orchestra BioMed Holdings, Inc. and Motus GI Holdings, Inc. Between 16 February 2018 and 26 August 2026, the trades on record add up to 22 filings.
No open-market sale appears; the market trades are 6 purchases worth €21k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 16 share grants.
Half of the purchases are above €3,382 and half below. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 28 August 2026: a share grant of €14k, in Orchestra BioMed Holdings, Inc. The last insider purchase was made public on 25 August 2025, 425 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrew Lawrence Taylor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
3,076 shares@ US$5.26Common Stock, par value $0.0001 per shareSEC:0001104659-26-103210:0
181,000 shares0Common Stock, par value $0.0001 per shareSEC:0001104659-26-015320:0
3,452 shares@ US$4.313.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-26-000272:0
8,670 shares@ US$4.6710.5% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-25-120668:0
3,071 shares@ US$5.354.8% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-25-116432:0
16,102 shares@ US$2.4611.8% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-25-091743:0
2,000 shares@ US$2.551.8% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-25-082633:0
Canonical exit: 23 Nov 2025 (T+90)
80,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-075789:0
28,172 shares@ US$3.1431.2% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-059418:0
84,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-032330:0
1,000 shares@ US$4.832.8% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-24-130521:0
Canonical exit: 19 Mar 2025 (T+90)
34,403 shares@ US$5.0397.2% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-24-128431:0
100,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-24-059991:0
278,363 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-23-083501:0
95,000 shares0Common Stock, par value $0.0001 per shareSEC:0001493152-22-004082:0
2,000 shares@ €0.4491100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001213900-21-061014:0
Canonical exit: 17 Feb 2022 (T+90)
16 of 16 declarations
